Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBerkeley Eng Regulatory News (BKY)

Share Price Information for Berkeley Eng (BKY)

Share Price is delayed by 15 minutes
Get Live Data
25.10    0.90 (3.67%)
Bid:
24.80
Ask:
25.40
Spread: 0.60 (2.419%)
Market Cap: £113.36m
BKY Live PriceLast checked at - London Stock Exchange

Intraday Berkeley Eng Share Chart

Permitting Update

29 Nov 2021 07:00

RNS Number : 8479T
Berkeley Energia Limited
29 November 2021
Β 

BERKELEY ENERGIA LIMIETD

Β 

NEWS RELEASE | 29 November 2021

Β 

Permitting Update

Β 

Berkeley Energia Limited ("Berkeley" or the "Company") has received formal notification from the Ministry for Ecological Transition and the Demographic Challenge ("MITECO") that it has rejected the Authorisation for Construction for the uranium concentrate plant as a radioactive facility ("NSC II") at the Company's Salamanca project.

Β 

This follows theΒ unfavourable report for the grant of NSC II issued by the Board of the Nuclear Safety Council ("NSC") announced on 12 July 2021.

Β 

As previously reported, Berkeley strongly refutes the NSC's assessment and, in the Company's opinion, the NSC has adopted an arbitrary decision with the technical issues used as justification to issue the unfavourable report lacking in both technical and legal support.

Β 

Berkeley submitted documentation, including an 'Improvement Report' to supplement the Company's initial NSC II application, along with the corresponding arguments that address all of the issues raised by the NSC, and a request for its reassessment by the NSC, to MITECO in late July (see announcement dated 23 July 2021).

Β 

The Improvement Report was complemented by an Independent Expert's technical opinion on the hydrogeological aspects of the project produced by Prof. Rafael FernΓ‘ndez Rubio, Emeritus Professor of Hydrogeology at the Polytechnic University of Madrid.

Β 

Further documentation was submitted to MITECO in early August, in which the Company, with strongly supported arguments, dismantled all of the technical issues used by the NSC as justification to issue the unfavourable report. The Company again restated that the project is compliant with all requirements for NSC II to be awarded and requested its NSC II Application be reassessed by the NSC (see announcement dated 5 August 2021).

Β 

These submissions to MITECO were made as part of the previously disclosed hearing process in relation to the unfavourable NSC II decision.

Β 

In addition, the Company requested from MITECO access to the files associated with the Authorisation for Construction and Authorisation for Dismantling and Closure for the radioactive facilities at La Haba (Badajoz) and Saelices El Chico (Salamanca), which are owned by ENUSA Industrias Avandas S.A., in order to verify and contrast the conditions approved by the competent administrative and regulatory bodies for other similar uranium projects in Spain.

Β 

Based on a detailed comparison of the different licensing files undertaken by the Company following receipt of these files, it is clear that Berkeley, in its NSC II submission, has been required to provide information that does not correspond to: (i) the regulatory framework, (ii) the scope of the current procedural stage (i.e. at the NSC II stage), and/or (iii) the criteria applied in other licensing processes for similar radioactive facilities). Accordingly, the Company considers that the NSC has acted in a discriminatory and arbitrary manner when assessing the NSC II application for the Salamanca project.

Β 

These additional arguments were detailed in a further letter sent to MITECO in which Berkeley requested that the additional arguments be incorporated into its file and, in view of the outlined deficiencies of the NSC's unfavourable report, the procedure be returned to the NSC for a new report to be issued correcting these deficiencies (see announcement dated 29 October 2021).

Β 

In Berkeley's strong opinion, MITECO has rejected the Company's NSC II Application without following the legally established procedure, as the Improvement Report has not been taken into account and sent to the NSC for its assessment, as requested on multiple occasions by the Company.

Β 

In this regard, the Company believes that MITECO have infringed regulations on administrative procedures in Spain, as well as Berkeley's right of defence, which would imply that the decision on the rejection of the Company's NSC II Application is not legal.

Β 

The Company will continue to strongly defend its position and will immediately consider the range of legal options available to it in relation to the adverse resolution by MITECO.

Β 

The Company will continue to update the market on any material developments.

Β 

For further information please contact:

Β 

Robert Behets Franciso BellΓ³n

Acting Managing Director Chief Operations Officer

+61 8 9322 6322 +34 91 555 1380

info@berkeleyenergia.com

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCFESSEUEFSEEF
Date   Source Headline
4th Jan 20229:01 amRNSPrice Monitoring Extension
31st Dec 20217:00 amRNSReport on Payments to Govts
30th Nov 20217:00 amRNSConversion of Convertible Note
29th Nov 20219:05 amRNSSecond Price Monitoring Extn
29th Nov 20219:00 amRNSPrice Monitoring Extension
29th Nov 20217:00 amRNSPermitting Update
17th Nov 20217:00 amRNSResult of AGM
5th Nov 20217:00 amRNSOIA Claim
3rd Nov 20214:40 pmRNSSecond Price Monitoring Extn
3rd Nov 20214:35 pmRNSPrice Monitoring Extension
3rd Nov 20212:06 pmRNSSecond Price Monitoring Extn
3rd Nov 20212:00 pmRNSPrice Monitoring Extension
2nd Nov 20212:05 pmRNSSecond Price Monitoring Extn
2nd Nov 20212:00 pmRNSPrice Monitoring Extension
2nd Nov 20217:16 amRNSASX Trading Halt
29th Oct 20217:00 amRNSQuarterly Report September 2021
26th Oct 20217:00 amRNSResignation of Director
12th Oct 20217:00 amRNSNotice of AGM
17th Sep 20217:50 amRNSDate of Annual General Meeting
31st Aug 20217:00 amRNSAnnual Report to shareholders
5th Aug 20217:28 amRNSPermitting Update
30th Jul 20217:00 amRNSQuarterly Report June 2021
23rd Jul 20218:29 amRNSPermitting Update
16th Jul 202111:05 amRNSSecond Price Monitoring Extn
16th Jul 202111:00 amRNSPrice Monitoring Extension
15th Jul 20214:40 pmRNSSecond Price Monitoring Extn
15th Jul 20214:35 pmRNSPrice Monitoring Extension
13th Jul 202111:05 amRNSSecond Price Monitoring Extn
13th Jul 202111:00 amRNSPrice Monitoring Extension
13th Jul 20219:05 amRNSSecond Price Monitoring Extn
13th Jul 20219:00 amRNSPrice Monitoring Extension
12th Jul 20214:41 pmRNSSecond Price Monitoring Extn
12th Jul 20214:35 pmRNSPrice Monitoring Extension
12th Jul 20212:05 pmRNSSecond Price Monitoring Extn
12th Jul 20212:00 pmRNSPrice Monitoring Extension
12th Jul 20211:45 pmRNSPermitting Update
25th Jun 20218:29 amRNSAdmission of shares to trading
20th May 20212:05 pmRNSSecond Price Monitoring Extn
20th May 20212:00 pmRNSPrice Monitoring Extension
14th May 20217:00 amRNSUpdate on Spanish Regulatory Regime
29th Apr 20217:00 amRNSQuarterly Report March 2021
9th Apr 20217:00 amRNSUpdate on Spanish Regulatory Regime
26th Mar 20217:00 amRNSIssue of shares on exercise of unlisted options
10th Mar 20217:00 amRNSHalf-year Report
25th Feb 20214:41 pmRNSSecond Price Monitoring Extn
25th Feb 20214:35 pmRNSPrice Monitoring Extension
24th Feb 20214:41 pmRNSSecond Price Monitoring Extn
24th Feb 20214:35 pmRNSPrice Monitoring Extension
24th Feb 20212:06 pmRNSSecond Price Monitoring Extn
24th Feb 20212:01 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.